NAUT Nautilus Biotechnology, Inc.
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1808805 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY6.7%
TTM EPS YoY8.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-41.0%
ROA-33.5%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets21.7%
Debt / equity0.00x
Current ratio9.25x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.90x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $41.11M | $50.48M |
| SG&A expense | $25.73M | $31.00M |
| Income tax | $0 | $0 |
| Net income | -$59.00M | -$70.78M |
| EPS (basic) | -0.47 | -0.56 |
| EPS (diluted) | -0.47 | -0.56 |
| Weighted avg. shares (diluted) | 126.26M | 125.43M |
| Balance sheet | ||
| Cash & equivalents | $12.39M | $28.65M |
| Short-term investments | $91.02M | $102.25M |
| Current assets | $105.96M | $132.83M |
| PP&E, net | $3.46M | $4.08M |
| Total assets | $191.11M | $242.74M |
| Current liabilities | $7.95M | $7.63M |
| Total liabilities | $34.14M | $34.01M |
| Shareholders' equity | $156.97M | $208.73M |
| Shares outstanding | 126.47M | 126.11M |
| Cash flow statement | ||
| Operating cash flow | -$50.70M | -$59.15M |
| Capital expenditure | $1.28M | $2.12M |
| Free cash flow | -$51.97M | -$61.27M |
| Investing cash flow | $35.22M | $66.25M |
| Financing cash flow | $214,000 | $1.14M |
| Depreciation & amortization | $1.70M | $2.00M |
| Stock-based compensation | $6.84M | $12.70M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.